[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369143-105":59,"doc-detail-369143-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","impact-of-helicobacter-pylori-infection-on-neoadjuvant-chemotherapy-in-locally-advanced-gastric-cancer-a-retrospective-analysis","Impact of Helicobacter pylori infection on neoadjuvant chemotherapy in locally advanced gastric cancer - a retrospective analysis","","Helicobacter pylori (H. pylori) infection may influence treatment outcomes in gastric cancer, yet its specific impact on neoadjuvant chemotherapy for locally advanced gastric cancer (LAGC) is insufficiently defined. This retrospective cohort examined patients receiving neoadjuvant chemotherapy and surgery at the Sixth Affiliated Hospital of Sun Yat-sen University. Patients were stratified by H. pylori infection status and treatment response, oncological outcomes, and prognosis were compared, including major pathological response and survival metrics.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/impact-of-helicobacter-pylori-infection-on-neoadjuvant-chemotherapy-in-locally-advanced-gastric-cancer-a-retrospective-analysis/369143/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/impact-of-helicobacter-pylori-infection-on-neoadjuvant-chemotherapy-in-locally-advanced-gastric-cancer-a-retrospective-analysis/369143.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the purpose of this study on H. pylori and neoadjuvant chemotherapy?","Question",{"text":112,"@type":113},"To investigate how H. pylori infection affects neoadjuvant chemotherapy response and prognosis in patients with locally advanced gastric cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were patients grouped in the retrospective analysis?",{"text":117,"@type":113},"Patients with locally advanced gastric cancer who received neoadjuvant chemotherapy and surgery were grouped by their H. pylori infection status (H. pylori-positive vs H. pylori-negative).",{"name":119,"@type":110,"acceptedAnswer":120},"What outcomes were compared between H. pylori-positive and H. pylori-negative groups?",{"text":121,"@type":113},"The study compared responses to neoadjuvant chemotherapy and oncological outcomes, including major pathological response and survival measures such as overall survival and disease-free survival.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369143,1790327331,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Zhong et al. BMC Cancer (2025) 25:157 BMC Cancer  \n[https://doi.org/10.1186/s12885-025-13494-5](https://doi.org/10.1186/s12885-025-13494-5)  \nRESEARCH Open Access  \nImpact of Helicobacter pylori infection on neoadjuvant chemotherapy in locally advanced gastric cancer: a retrospective analysis  \nBin Zhong 1,2†, Zhizhong Xiong 1,2†, Jiabo Zheng 1,2†, Saddam Ahmed Mohamed 1,2, Jiachen Sun 1,4, Dayin Huang 1,2, Zijian Deng 1,2, Jianping Guo 1,2, Junsheng Peng 1,2*, Huashe Wang 1,2* and Lei Lian 1,2,3*  \nAbstract  \nBackground Helicobacter pylori (H. pylori) infection may affect the efficacy of immunotherapy and adjuvant chemotherapy in gastric cancer patients. However, the role of H. pylori infection in neoadjuvant chemotherapy inpatients with locally advanced gastric cancer (LAGC) remains unclear. This study investigated the effect of H. pylori infection on neoadjuvant chemotherapy and prognosis of patients with LAGC.  \nMethods This retrospective study utilized data from patients with LAGC who underwent neoadjuvant chemotherapy and surgical treatment at the Sixth Affiliated Hospital of Sun Yat-sen University from January 1, 2010, to January  \n31, 2021. Patients were grouped according to their H. pylori infection status. The responses ofthe two groups toneoadjuvant chemotherapy and oncological outcomes were then compared.  \nResults A total of 239 patients were included in the analysis, and the baseline characteristics of the H. pylori-positive (n = 51) and H. pylori-negative (n = 188) groups were comparable. Further analysis revealed that H. pylori infection was significantly associated with the major pathological response (P = 0 . 009) . Multivariate analysis showed that factors related to major pathological response included; age ≤ 50 (OR: 0 .423, 95% CI: 0 .194–0. 925), H. pylori infection (OR:  \n0. 396, 95% CI: 0 .183–0. 854), pathological stage T 3/4 (OR: 0 . 524, 95% CI: 0 .288–0. 954), and CA12-5 > 35 U/mL (OR: 0. 345, 95% CI: 0 .132–0. 904) . Both overall survival (OS) and disease-free survival (DFS) rates were poorer in the H. pyloripositive group than in the H. pylori-negative group (OS: Log-Rank P= 0 . 035; DFS: Log-Rank P= 0 . 029) .  \n†Bin Zhong, Zhizhong Xiong and Jiabo Zheng contributed equally to this work.  \n*Correspondence: Junsheng Peng [pengjsh@mail.sysu.edu.cn](pengjsh@mail.sysu.edu.cn)[ ](pengjsh@mail.sysu.edu.cn)Huashe Wang [wanghsh@mail.sysu.edu.cn](wanghsh@mail.sysu.edu.cn)[ ](wanghsh@mail.sysu.edu.cn)Lei Lian [lianlei2@mail.sysu.edu.cn](lianlei2@mail.sysu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nZhong et al. BMC Cancer (2025) 25:157 Page 2 of 12  \nConclusion This cohort study indicated that H. pylori infection may be associated with tumor response toneoadjuvant chemotherapy and survival outcomes in patients with LAGC.  \nKeywords Locally advanced gastric cancer, Helicobacter pylori, Neoadjuvant chemother","cbCaihrsTaGdOoO8","https://ap.wps.com/l/cbCaihrsTaGdOoO8","pdf",2109530,12,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the purpose of this study on H. pylori and neoadjuvant chemotherapy?\",\"answer\":\"To investigate how H. pylori infection affects neoadjuvant chemotherapy response and prognosis in patients with locally advanced gastric cancer.\"},{\"question\":\"How were patients grouped in the retrospective analysis?\",\"answer\":\"Patients with locally advanced gastric cancer who received neoadjuvant chemotherapy and surgery were grouped by their H. pylori infection status (H. pylori-positive vs H. pylori-negative).\"},{\"question\":\"What outcomes were compared between H. pylori-positive and H. pylori-negative groups?\",\"answer\":\"The study compared responses to neoadjuvant chemotherapy and oncological outcomes, including major pathological response and survival measures such as overall survival and disease-free survival.\"}]","Impact of Helicobacter pylori infection on neoadjuvant chemotherapy in locally advanced gastric cancer - a retrospective analysis | PDF",1790180962,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d772a7f419effd2c9fd29c6d2eedb12.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e92381e601a4d7532c4b0027a76eefae.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2607fff7c86f2db4f8994adc8475d6b5.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eace40e1434ffab7fad366dbd3e8bb66.webp",980,1306]